Form 4 for CDLX Cardlytics, Inc.
Accepted 2023-12-05 00:00:00 ET · period of report 2023-12-01 · accession 0001666071-23-000152 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-12-05 | 2023-12-05 | CDLX | Temsamani Karim Saad | CEO, Dir | S - Sale+OE | $8.21 | -40.4K | 258.9K | -14% | -$331.8K |
| D | 2023-12-05 | 2023-12-01 | CDLX | Temsamani Karim Saad | CEO, Dir | M - OptEx | $0.00 | +84.1K | 299.3K | +39% | $0 |
| D | 2023-12-05 | 2023-12-01 | CDLX | Temsamani Karim Saad | CEO, Dir | M - OptEx | $0.00 | -84.1K | 924.9K | -8% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-05 | S | D | 40,413 | $8.21 | 258,858 | D | — | — | (F2) Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for restricted stock units that vested on December 1, 2023. (F3) The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $8.02 to $8.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2023-12-01 | M | A | 84,079 | $0.00 | 299,271 | D | — | — | (F1) Represents the underlying vested shares of common stock of the Issuer. |
| 3 | Derivative | Restricted Stock Unit | 2023-12-01 | M | D | 84,079 | $0.00 | 924,867 | D | — · — to — | 84,079 Common Stock | (F4) Each RSU represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. (F5) 25% of the RSUs vested on September 1, 2023 with the remaining 75% vesting in equal amounts over the subsequent three years quarterly thereafter, provided that the Reporting Person remains employed by the Issuer on such vesting date. |